Unitedhealth Group Inc
Research Unitedhealth Group Inc (UNH) on Bullrun: valuation model: 11.7% overvalued, market cap USD 343.27B, P/E 24.4, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerUNH
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryHealthcare Plans
- CurrencyUSD
- Valuation signal11.7% overvalued
- Market capUSD 343.27B
- P/E24.4
- Dividend yield2.4%
- Financial periodQ2 2026
- RevenueUSD 112.03B
- Net incomeUSD 5.48B
- Free cash flowUSD 10.25B
- Gross margin20.8%
Valuation Snapshot
Bullrun's latest valuation model marks Unitedhealth Group Inc as 11.7% overvalued; latest market cap is USD 343.27B; P/E is 24.4; dividend yield is 2.4%.
Peer valuation comparison
Latest P/E is 24.39x versus a Healthcare sector median of 24.61x.
Latest dividend yield is 2.39% versus a Healthcare sector median of 1.84% (29.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 447.57B | USD 12.06B | USD 16.08B | 88.7% | 13.23 | USD 24.37B | USD 78.39B | USD 100.09B |
| FY2024 | USD 400.28B | USD 14.41B | USD 20.71B | 88.3% | 15.51 | USD 25.31B | USD 76.90B | USD 98.27B |
| FY2023 | USD 371.62B | USD 22.38B | USD 25.68B | 89.6% | 23.86 | USD 25.43B | USD 62.54B | USD 94.42B |
| FY2022 | USD 324.16B | USD 20.12B | USD 23.40B | 89.6% | 21.18 | USD 23.37B | USD 57.62B | USD 81.45B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 343.27B | 24.4 | 2.4% | 9.06 |
| 2025 | 2025-12-31 | USD 299.03B | 25.0 | 2.6% | 8.73 |
| 2024 | 2024-12-31 | USD 462.86B | 32.6 | 1.6% | 8.18 |
| 2023 | 2023-12-29 | USD 486.95B | 22.9 | 1.4% | 7.29 |
| 2022 | 2022-12-30 | USD 495.37B | 26.0 | 1.2% | 6.4 |
| 2021 | 2021-12-31 | USD 472.51B | 27.8 | 1.1% | 5.6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 9.06 USD, yield 2.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 8.73 USD |
| FY2024 | 8.18 USD |
| FY2023 | 7.29 USD |
| FY2022 | 6.4 USD |
About Unitedhealth Group Inc
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities.
ETFs that hold Unitedhealth Group Inc
Unitedhealth Group Inc is one of the ten largest holdings of 43 ETFs that investors in Europe can buy. The 8 most traded of them:
Compare every fund on the same index:
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Unitedhealth Group Inc overvalued or undervalued?
Bullrun's valuation model currently marks Unitedhealth Group Inc as 11.7% overvalued.
What is Unitedhealth Group Inc's market cap?
Unitedhealth Group Inc's market capitalization is USD 343.27B.
What is Unitedhealth Group Inc's P/E ratio?
Unitedhealth Group Inc's price-to-earnings (P/E) ratio is 24.4.
Does Unitedhealth Group Inc pay a dividend?
Unitedhealth Group Inc has a dividend yield of 2.4%.
What does Unitedhealth Group Inc do?
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities.